SLC5A2 and obesity due to melanocortin 4 receptor deficiency: Obesity-oriented therapeutic compounds such as Sodium-Glucose Cotransporter-2 (SGLT2), statins and metformin all show tumor growth inhibitory effects, and reverse obesity-driven cancer aggressiveness [10,11,12].